Clinical Trials Browser

Phase 1/2 × Inflammatory Breast Neoplasms × Filgrastim × Clear all

NCT00002627 2014-01-10

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms